High Tech Pharm Co., Ltd. (KOSDAQ:106190)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,490
+620 (4.82%)
At close: Feb 6, 2026
-14.62%
Market Cap143.44B -8.5%
Revenue (ttm)75.60B -7.3%
Net Income11.98B -17.7%
EPS1,122.62 -45.3%
Shares Out10.63M
PE Ratio12.02
Forward PEn/a
Dividend100.00 (0.74%)
Ex-Dividend DateDec 29, 2025
Volume72,202
Average Volume31,727
Open12,870
Previous Close12,870
Day's Range12,450 - 13,505
52-Week Range10,700 - 16,430
Beta0.49
RSI78.76
Earnings DateFeb 5, 2026

About High Tech Pharm

High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1998
Employees 65
Stock Exchange KOSDAQ
Ticker Symbol 106190
Full Company Profile

Financial Performance

In 2024, High Tech Pharm's revenue was 77.51 billion, an increase of 0.97% compared to the previous year's 76.77 billion. Earnings were 13.71 billion, an increase of 69.75%.

Financial Statements